Skip to main content

WPI 2245 (Mesalamine Delayed-Release 1.2 g)

Pill with imprint WPI 2245 is Brown, Elliptical/Oval and has been identified as Mesalamine Delayed-Release 1.2 g. It is supplied by Actavis Pharma, Inc.

Mesalamine is used in the treatment of crohn's disease, maintenance; inflammatory bowel disease; ulcerative colitis, maintenance; ulcerative colitis; ulcerative proctitis and belongs to the drug class 5-aminosalicylates. excluding Asacol and Asacol HD: There is no proven risk in humans during pregnancy. Asacol and Asacol HD: Risk cannot be ruled out during pregnancy. Mesalamine 1.2 g is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2245

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.